Rady Childrens Hospital - San Diego
- Type
- Teaching hospital
- Where
- San Diego, CA
- Medicare CCN
- 053303
- Received
- $1,039,206 in 47 records, 2021 ($226,224 general, $812,981 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
- Nonprofit: RADY CHILDRENS HOSPITAL SAN DIEGO Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2021 | General payment | 28 | $226,224 |
| 2021 | Research payment | 19 | $812,981 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 4 | $417,927 | 2021 |
| Amgen Inc. | 1 | $333,513 | 2021 |
| Alexion Pharmaceuticals, Inc. | 5 | $221,975 | 2021 |
| Soleno Therapeutics, Inc. | 2 | $38,559 | 2021 |
| PFIZER INC. | 1 | $15,488 | 2021 |
| Cochlear Americas | 3 | $3,009 | 2021 |
| Johnson & Johnson Health Care Systems Inc. | 8 | $2,019 | 2021 |
| Boehringer Ingelheim France S.A.S. | 2 | $1,421 | 2021 |
| Boehringer Ingelheim Pharma GmbH & Co.KG | 1 | $1,349 | 2021 |
| Phadia US Inc. | 3 | $1,200 | 2021 |
| Linvatec Corporation | 1 | $664 | 2021 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $620 | 2021 |
| Medical Graphics Corporation | 1 | $299 | 2021 |
| Hikma Pharmaceuticals USA | 1 | $262 | 2021 |
| Siemens Medical Solutions USA, Inc. | 1 | $229 | 2021 |
| Stryker Corporation | 2 | $195 | 2021 |
| Masimo Corporation | 4 | $112 | 2021 |
| Eli Lilly and Company | 1 | $109 | 2021 |
| Bio-Rad Laboratories, Inc. | 2 | $82 | 2021 |
| Vero Biotech Inc. | 1 | $75 | 2021 |
| FUJIFILM SonoSite, Inc. | 1 | $67 | 2021 |
| Merck Sharp & Dohme LLC | 1 | $23 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 19 | $812,981 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 4 | $201,975 |
| Space rental or facility fees (teaching hospital only) | 2 | $20,240 |
| Debt forgiveness | 13 | $2,527 |
| Long term medical supply or device loan | 5 | $777 |
| Food and Beverage | 2 | $338 |
| Gift | 1 | $299 |
| Education | 1 | $67 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2021-12-31 | Soleno Therapeutics, Inc. | $37,744 | Research payment | Cash or cash equivalent | A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients w | 2021 | |
| 2021-12-31 | Soleno Therapeutics, Inc. | $815 | Research payment | Cash or cash equivalent | An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Controlled-Release Tablet in Patients with | 2021 | |
| 2021-12-31 | Linvatec Corporation | $664 | Long term medical supply or device loan | In-kind items and services | MICROFREE Device, ORTHOPEDIC SURGERY | 2021 | |
| 2021-12-31 | Siemens Medical Solutions USA, Inc. | $229 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-12-31 | Stryker Corporation | $105 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-12-31 | Stryker Corporation | $90 | Debt forgiveness | Cash or cash equivalent | 2021 | ||
| 2021-12-31 | Masimo Corporation | $28 | Long term medical supply or device loan | In-kind items and services | SET and rainbow SET Device, Devices | 2021 | |
| 2021-12-31 | Masimo Corporation | $28 | Long term medical supply or device loan | In-kind items and services | SedLine Device, Devices | 2021 | |
| 2021-12-31 | Masimo Corporation | $27 | Long term medical supply or device loan | In-kind items and services | SedLine Device, Devices | 2021 | |
| 2021-12-31 | Masimo Corporation | $27 | Long term medical supply or device loan | In-kind items and services | rainbow Acoustic Monitoring Device, Devices | 2021 | |
| 2021-12-31 | Merck Sharp & Dohme LLC | $23 | Research payment | In-kind items and services | SIVEXTRO Drug, INFECTIOUS DISEASE | Phase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-Day Comparator in Subjects 12 to 18 Years with c | 2021 |
| 2021-12-30 | Johnson & Johnson Health Care Systems Inc. | $910 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-12-06 | Cochlear Americas | $1,670 | Research payment | Cash or cash equivalent | Cochlear Osia OSI200 Implant Device, Implantable hearing solution | Osia 2 System in a pediatric expansion study | 2021 |
| 2021-12-02 | Johnson & Johnson Health Care Systems Inc. | $980 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-11-19 | JAZZ PHARMACEUTICALS INC. | $97,812 | Research payment | In-kind items and services | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A | 2021 |
| 2021-10-25 | Cochlear Americas | $1,099 | Research payment | In-kind items and services | Cochlear Osia OSI200 Implant Device, Implantable hearing solution | Osia 2 System in a pediatric expansion study | 2021 |
| 2021-09-24 | JAZZ PHARMACEUTICALS INC. | $97,812 | Research payment | In-kind items and services | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A | 2021 |
| 2021-09-02 | Phadia US Inc. | $600 | Research payment | In-kind items and services | ImmunoCAP Device, Allergy | CABAL 1718 The Microbiome, Asthma and Other Atopic Development in the Premature Population | 2021 |
| 2021-08-31 | Boehringer Ingelheim Pharma GmbH & Co.KG | $1,349 | Research payment | In-kind items and services | TRADJENTA Drug, DIABETES | 52 wks Eff. & Saf. Ph III in Paediatrics | 2021 |
| 2021-08-26 | Phadia US Inc. | $300 | Research payment | In-kind items and services | ImmunoCAP Device, Allergy | CABAL 1718 The Microbiome, Asthma and Other Atopic Development in the Premature Population | 2021 |
| 2021-06-24 | Cochlear Americas | $240 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode Device, Implantable hearing solution | 2021 | |
| 2021-06-14 | Boehringer Ingelheim France S.A.S. | $811 | Research payment | In-kind items and services | TRADJENTA Drug, DIABETES | 52 wks Eff. & Saf. Ph III in Paediatrics | 2021 |
| 2021-06-09 | Alexion Pharmaceuticals, Inc. | $84,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2021 | ||
| 2021-05-27 | Bio-Rad Laboratories, Inc. | $25 | Debt forgiveness | Cash or cash equivalent | Biotestcell 1 & 2 Device, Antiglobulin test | 2021 | |
| 2021-05-26 | Johnson & Johnson Health Care Systems Inc. | $44 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-05-19 | Alexion Pharmaceuticals, Inc. | $20,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2021 | ||
| 2021-05-18 | FUJIFILM SonoSite, Inc. | $67 | Education | In-kind items and services | SonoSite Edge II Device, Medical Device | 2021 | |
| 2021-05-06 | Boehringer Ingelheim France S.A.S. | $610 | Research payment | In-kind items and services | TRADJENTA Drug, DIABETES | 52 wks Eff. & Saf. Ph III in Paediatrics | 2021 |
| 2021-04-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | $620 | Research payment | In-kind items and services | TRADJENTA Drug, DIABETES | 52 wks Eff. & Saf. Ph III in Paediatrics | 2021 |
| 2021-04-09 | Hikma Pharmaceuticals USA | $262 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-04-09 | Johnson & Johnson Health Care Systems Inc. | $18 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-04-09 | Johnson & Johnson Health Care Systems Inc. | $16 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-04-07 | PFIZER INC. | $15,488 | Research payment | In-kind items and services | XALKORI Drug, ONCOLOGY | FULL A PHASE III STUDY OF 131IMETAIODOBENZYLGUANIDINE 131IMIBG OR CRIZOTINIB FOR TREATMENT OF CHILDREN WITH NEWLY DIAGNO | 2021 |
| 2021-03-30 | Johnson & Johnson Health Care Systems Inc. | $30 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-03-30 | Johnson & Johnson Health Care Systems Inc. | $4 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-03-19 | Amgen Inc. | $333,513 | Research payment | In-kind items and services | Blincyto Biological, Oncology | TOTAL THERAPY STUDY XVII (TOTXVII) FOR NEWLY DIAGNOSED PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOM | 2021 |
| 2021-03-17 | Vero Biotech Inc. | $75 | Food and Beverage | Cash or cash equivalent | Genosyl Drug, Respiratory Therapy | 2021 | |
| 2021-03-16 | JAZZ PHARMACEUTICALS INC. | $88,920 | Research payment | In-kind items and services | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A | 2021 |
| 2021-03-10 | Alexion Pharmaceuticals, Inc. | $51,589 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2021 | ||
| 2021-02-25 | JAZZ PHARMACEUTICALS INC. | $133,381 | Research payment | In-kind items and services | VYXEOS Drug, HEMATOLOGY/ONCOLOGY | A STUDY TO COMPARE STANDARD CHEMOTHERAPY TO THERAPY WITH CPX-351 AND/OR GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED A | 2021 |
| 2021-02-16 | Johnson & Johnson Health Care Systems Inc. | $15 | Debt forgiveness | In-kind items and services | 2021 | ||
| 2021-01-29 | Bio-Rad Laboratories, Inc. | $57 | Debt forgiveness | Cash or cash equivalent | Biotestcell 1 & 2 Device, Antiglobulin test | 2021 | |
| 2021-01-26 | Eli Lilly and Company | $109 | Research payment | In-kind items and services | A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG WITH AN OPEN-LABEL POSTPRANDIAL LY900014 TREAT | 2021 | |
| 2021-01-22 | Medical Graphics Corporation | $299 | Gift (2 payments) | In-kind items and services | 2021 | ||
| 2021-01-13 | Alexion Pharmaceuticals, Inc. | $52,810 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2021 | ||
| 2021-01-13 | Alexion Pharmaceuticals, Inc. | $12,650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2021 | ||
| 2021-01-07 | Phadia US Inc. | $300 | Research payment | In-kind items and services | ImmunoCAP Device, Allergy | CABAL 1718 The Microbiome, Asthma and Other Atopic Development in the Premature Population | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In San Diego, CA, county San Diego County, CA, state California; placed by its city name.
| Measure | Place (city or town) San Diego, CA | County San Diego County, CA | State California |
|---|---|---|---|
| Population B01003 | 1,389,526 | 3,288,774 | 39,287,377 |
| Population, 2020 census P1 | 1,386,932 | 3,298,634 | 39,538,223 |
| Median age B01002 | 36.2 | 37.3 | 37.9 |
| Under 18 B01001 | 18.4% | 20.9% | 22.0% |
| 65 and over B01001 | 14.6% | 15.4% | 15.7% |
| Households B11001 | 530,412 | 1,171,278 | 13,548,091 |
| Foreign born B05002 | 25.1% | 22.8% | 27.0% |
| Median household income B19013 | $108,077 | $106,268 | $99,122 |
| Median family income B19113 | $128,006 | $122,377 | $113,346 |
| Per capita income B19301 | $57,083 | $51,976 | $49,513 |
| Poverty rate B17001 | 11.0% | 10.3% | 12.0% |
| Unemployment rate B23025 | 6.0% | 6.1% | 6.6% |
| Civilian labor force B23025 | 755,893 | 1,689,384 | 20,068,466 |
| Mean commute (minutes) B08013 | 23.5 | 25.5 | 28.7 |
| Bachelor's degree or higher B15003 | 51.0% | 43.2% | 37.1% |
| Housing units B25001 | 568,668 | 1,250,641 | 14,644,735 |
| Owner-occupied B25003 | 47.3% | 54.6% | 55.9% |
| Renters B25003 | 52.7% | 45.4% | 44.1% |
| Median home value B25077 | $906,700 | $854,700 | $734,700 |
| Median gross rent B25064 | $2,313 | $2,246 | $2,036 |
| White, not Hispanic B03002 | 40.9% | 42.4% | 33.8% |
| Black B03002 | 5.3% | 4.4% | 5.2% |
| Hispanic or Latino B03002 | 29.8% | 34.6% | 40.2% |
| Asian B03002 | 17.3% | 12.1% | 15.3% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in San Diego, CA.
Comments